Biopharmaceutical company CASI Pharmaceuticals, Inc. (CASI) announced Monday the appointment of Daniel Lang as Chief Financial Officer and Senior Vice President, effective July 8, 2024.
Lang has more than 30 years of experience as a physician scientist, investor, and biotech executive. He is a cardiologist by training from UCSF, followed by 20 years of investment experience as a portfolio manager at Farallon Capital and Chief Investment Officer at RS Investments Value Group.
Most recently, he was the President of Athenex cell therapy division and led clinical development of the NKT cell platform.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.